CONSETT MEDICAL CENTRE
STATION YARD, CONSETTCKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 572 | 856 | 66.8% | |
CKD 4 | 2008 | 655 | 985 | 66.5% | |
CKD 5 | 2009 | 130 | 166 | 78.3% | |
CKD 5 | 2010 | 104 | 120 | 86.7% | |
CKD 5 | 2011 | 90 | 103 | 87.4% | |
CKD 5 | 2012 | 74 | 90 | 82.2% | |
CKD 5 | 2013 | 71 | 84 | 84.5% | |
CKD003 | 2014 | 65 | 78 | 83.3% | |
CKD003 | 2015 | 64 | 72 | 88.9% | |
NM84 | 2016 | 54 | 71 | 76.1% | |
NM84 | 2017 | 43 | 64 | 67.2% | |
NM84 | 2018 | 37 | 52 | 71.2% | |
NM84 | 2019 | 29 | 43 | 67.4% | |
NM84 | 2020 | 29 | 52 | 55.8% | |
NM84 | 2022 | 34 | 42 | 81.0% | |
NM84 | 2023 | 36 | 52 | 69.2% |